Treatment Option for Patients with Recurrent Platinum-Resistant Ovarian Cancer

We would like to invite you to participate in an ongoing clinical trial which presents a new investigational treatment option. This treatment may be relevant for you, if you are:

• Age 18 or above

• Having Platinum Resistant Ovarian tumor that has returned after being treated

Women who will be found eligible, will be treated with a medication that’s already approved to treat ovarian cancer, combined with the investigational medication or with placebo.